{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:32:23Z","timestamp":1793140343344,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001695","name":"Japan Science and Technology Corporation","doi-asserted-by":"publisher","award":["JPMJSP2130"],"award-info":[{"award-number":["JPMJSP2130"]}],"id":[{"id":"10.13039\/501100001695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008886","name":"Princess Takamatsu Cancer Research Fund","doi-asserted-by":"publisher","award":["20-25225"],"award-info":[{"award-number":["20-25225"]}],"id":[{"id":"10.13039\/501100008886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00204-025-04075-3","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T08:20:10Z","timestamp":1749457210000},"page":"3393-3412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hepatic stellate cell inhibition by angiotensin II receptor blocker mitigates liver injury and fibrosis via NF-\u03baB-galectin-3 suppression in a rat nonalcoholic steatohepatitis model"],"prefix":"10.1007","volume":"99","author":[{"given":"Xiaochen","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0828-2033","authenticated-orcid":false,"given":"Aya","family":"Naiki-Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Nagayasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"8","key":"4075_CR1","doi-asserted-by":"publisher","first-page":"E1926","DOI":"10.1073\/pnas.1714377115","volume":"115","author":"M Adler","year":"2018","unstructured":"Adler M, Mayo A, Zhou X et al (2018) Endocytosis as a stabilizing mechanism for tissue homeostasis. Proc Natl Acad Sci 115(8):E1926\u2013E1935","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4075_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/nu14010042","volume":"14","author":"Y Aoyama","year":"2021","unstructured":"Aoyama Y, Naiki-Ito A, Xiaochen K et al (2021) Lactoferrin prevents hepatic injury and fibrosis via the inhibition of NF-\u03baB signaling in a rat non-alcoholic steatohepatitis model. Nutrients 14(1):42","journal-title":"Nutrients"},{"issue":"1","key":"4075_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/hep.20256","volume":"40","author":"M Asamoto","year":"2004","unstructured":"Asamoto M, Hokaiwado N, Murasaki T, Shirai T (2004) Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals. Hepatology 40(1):205\u2013210","journal-title":"Hepatology"},{"issue":"2","key":"4075_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Investig 115(2):209\u2013218","journal-title":"J Clin Investig"},{"issue":"6","key":"4075_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0016-5085(00)70368-4","volume":"118","author":"R Bataller","year":"2000","unstructured":"Bataller R, Gin\u00e8s P, Nicol\u00e1s JM et al (2000) Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118(6):1149\u20131156","journal-title":"Gastroenterology"},{"issue":"1","key":"4075_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","volume":"6","author":"K Begriche","year":"2006","unstructured":"Begriche K, Igoudjil A, Pessayre D, Fromenty B (2006) Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6(1):1\u201328","journal-title":"Mitochondrion"},{"issue":"4","key":"4075_CR7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jhep.2004.02.013","volume":"40","author":"SH Caldwell","year":"2004","unstructured":"Caldwell SH, Crespo DM (2004) The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 40(4):578\u2013584","journal-title":"J Hepatol"},{"issue":"12","key":"4075_CR8","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1038\/s41374-018-0119-3","volume":"98","author":"Z Cao","year":"2018","unstructured":"Cao Z, Hao Z, Xin M et al (2018) Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44. Lab Invest 98(12):1642\u20131656","journal-title":"Lab Invest"},{"issue":"1","key":"4075_CR9","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1152\/ajpgi.00419.2002","volume":"285","author":"T Chiu","year":"2003","unstructured":"Chiu T, Santiskulvong C, Rozengurt E (2003) ANG II stimulates PKC-dependent ERK activation, DNA synthesis, and cell division in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 285(1):G1\u2013G11","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4075_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-7-4","volume":"7","author":"HA Dbouk","year":"2009","unstructured":"Dbouk HA, Mroue RM, El-Sabban ME, Talhouk RS (2009) Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun Signal 7:1\u201317","journal-title":"Cell Commun Signal"},{"issue":"3","key":"4075_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","volume":"52","author":"M De Gasparo","year":"2000","unstructured":"De Gasparo M, Catt K, Inagami T, Wright J, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52(3):415\u2013472","journal-title":"Pharmacol Rev"},{"key":"4075_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11901-017-0378-2","volume":"16","author":"M Ekstedt","year":"2017","unstructured":"Ekstedt M, Nasr P, Kechagias S (2017) Natural history of NAFLD\/NASH. Curr Hepatol Rep 16:391\u2013397","journal-title":"Curr Hepatol Rep"},{"issue":"1","key":"4075_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73(1):202\u2013209","journal-title":"J Hepatol"},{"issue":"4","key":"4075_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jcp.30956","volume":"238","author":"D Ezhilarasan","year":"2023","unstructured":"Ezhilarasan D (2023a) Unraveling the pathophysiologic role of galectin-3 in chronically injured liver. J Cell Physiol 238(4):673\u2013686. https:\/\/doi.org\/10.1002\/jcp.30956","journal-title":"J Cell Physiol"},{"issue":"4","key":"4075_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/jcp.30956","volume":"238","author":"D Ezhilarasan","year":"2023","unstructured":"Ezhilarasan D (2023b) Unraveling the pathophysiologic role of galectin-3 in chronically injured liver. J Cell Physiol 238(4):673\u2013686","journal-title":"J Cell Physiol"},{"issue":"6","key":"4075_CR16","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1053\/jhep.1996.v23.pm0008675166","volume":"23","author":"F Farinati","year":"1996","unstructured":"Farinati F, Cardin R, D\u2019Errico A et al (1996) Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIB1 Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology 23(6):1468\u20131475. https:\/\/doi.org\/10.1053\/jhep.1996.v23.pm0008675166","journal-title":"Hepatology"},{"issue":"11","key":"4075_CR17","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/ijms20112700","volume":"20","author":"B Foglia","year":"2019","unstructured":"Foglia B, Cannito S, Bocca C, Parola M, Novo E (2019) ERK pathway in activated, myofibroblast-like, hepatic stellate cells: a critical signaling crossroad sustaining liver fibrosis. Int J Mol Sci 20(11):2700","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4075_CR18","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","volume":"98","author":"SJ Forrester","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD et al (2018) Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev 98(3):1627\u20131738","journal-title":"Physiol Rev"},{"issue":"6","key":"4075_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/liv.14478","volume":"40","author":"Y Fouad","year":"2020","unstructured":"Fouad Y, Waked I, Bollipo S, Gomaa A, Ajlouni Y, Attia D (2020) What\u2019s in a name? Renaming \u2018NAFLD\u2019to \u2018MAFLD.\u2019 Liver Int 40(6):1254\u20131261","journal-title":"Liver Int"},{"key":"4075_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.matbio.2017.12.013","volume":"68","author":"H Fran\u00e7ois","year":"2018","unstructured":"Fran\u00e7ois H, Chatziantoniou C (2018) Renal fibrosis: recent translational aspects. Matrix Biol 68:318\u2013332","journal-title":"Matrix Biol"},{"key":"4075_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"SL Friedman","year":"2003","unstructured":"Friedman SL (2003) Liver fibrosis\u2013from bench to bedside. J Hepatol 38:38\u201353","journal-title":"J Hepatol"},{"issue":"2","key":"4075_CR22","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/nu11020454","volume":"11","author":"G Fr\u00fchbeck","year":"2019","unstructured":"Fr\u00fchbeck G, Catal\u00e1n V, Rodr\u00edguez A et al (2019) Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients 11(2):454","journal-title":"Nutrients"},{"issue":"11","key":"4075_CR23","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms21113863","volume":"21","author":"H Fujii","year":"2020","unstructured":"Fujii H, Kawada N (2020) The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci 21(11):3863","journal-title":"Int J Mol Sci"},{"key":"4075_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/VHRM.S337640","volume":"18","author":"G Gallo","year":"2022","unstructured":"Gallo G, Volpe M, Rubattu S (2022) Angiotensin receptor blockers in the management of hypertension: a real-world perspective and current recommendations. Vasc Health Risk Manag 18:507\u2013515","journal-title":"Vasc Health Risk Manag"},{"issue":"3","key":"4075_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/liv.12611","volume":"35","author":"GB Goh","year":"2015","unstructured":"Goh GB, Pagadala MR, Dasarathy J et al (2015) Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease. Liver Int 35(3):979\u2013985","journal-title":"Liver Int"},{"issue":"Suppl","key":"4075_CR26","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3350\/cmh.2022.0424","volume":"29","author":"SK Han","year":"2023","unstructured":"Han SK, Baik SK, Kim MY (2023) Non-alcoholic fatty liver disease: definition and subtypes. Clin Mol Hepatol 29(Suppl):S5","journal-title":"Clin Mol Hepatol"},{"key":"4075_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00535-008-2262-x","volume":"44","author":"E Hashimoto","year":"2009","unstructured":"Hashimoto E, Yatsuji S, Tobari M et al (2009) Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 44:89\u201395","journal-title":"J Gastroenterol"},{"issue":"12","key":"4075_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116163","volume":"9","author":"M Hayashi","year":"2014","unstructured":"Hayashi M, Takeshita K, Uchida Y et al (2014) Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance. PLoS ONE 9(12):e116163","journal-title":"PLoS ONE"},{"issue":"17","key":"4075_CR29","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.3390\/cells12172129","volume":"12","author":"S Hora","year":"2023","unstructured":"Hora S, Wuestefeld T (2023) Liver injury and regeneration: current understanding, new approaches, and future perspectives. Cells 12(17):2129","journal-title":"Cells"},{"key":"4075_CR30","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.2741\/2349","volume":"12","author":"M Jaggi","year":"2007","unstructured":"Jaggi M, Du C, Zhang W, Balaji KC (2007) Protein kinase D1: a protein of emerging translational interest. Front Biosci 12:3757\u20133767","journal-title":"Front Biosci"},{"issue":"1","key":"4075_CR31","first-page":"99","volume":"14","author":"M Jamaluddin","year":"2000","unstructured":"Jamaluddin M, Meng T, Sun J, Boldogh I, Han Y, Brasier AR (2000) Angiotensin II induces nuclear factor (NF)-\u03baB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-\u03baB activation. Mol Endocrinol 14(1):99\u2013113","journal-title":"Mol Endocrinol"},{"issue":"4","key":"4075_CR32","first-page":"755","volume":"21","author":"G Jia","year":"2002","unstructured":"Jia G, Tohyama C, Sone H (2002) DNA damage triggers imbalance of proliferation and apoptosis during development of preneoplastic foci in the liver of Long-Evans Cinnamon rats. Int J Oncol 21(4):755\u2013761","journal-title":"Int J Oncol"},{"issue":"4","key":"4075_CR33","doi-asserted-by":"publisher","first-page":"G439","DOI":"10.1152\/ajpgi.00257.2011","volume":"302","author":"JX Jiang","year":"2012","unstructured":"Jiang JX, Chen X, Hsu DK et al (2012) Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo. Am J Physiol Gastrointest Liver Physiol 302(4):G439\u2013G446. https:\/\/doi.org\/10.1152\/ajpgi.00257.2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"4075_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/abbi.1997.0447","volume":"349","author":"MM Kadrofske","year":"1998","unstructured":"Kadrofske MM, Openo KP, Wang JL (1998) The HumanLGALS3 (Galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch Biochem Biophys 349(1):7\u201320","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"4075_CR35","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/10409238.2012.694843","volume":"47","author":"NS Kalupahana","year":"2012","unstructured":"Kalupahana NS, Moustaid-Moussa N (2012) The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms. Crit Rev Biochem Mol Biol 47(4):379\u2013390","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"2","key":"4075_CR36","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.18632\/oncotarget.6511","volume":"7","author":"H Kato","year":"2016","unstructured":"Kato H, Naiki-Ito A, Naiki T et al (2016) Connexin 32 dysfunction promotes ethanol-related hepatocarcinogenesis via activation of Dusp1-Erk axis. Oncotarget 7(2):2009","journal-title":"Oncotarget"},{"issue":"11","key":"4075_CR37","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/pharmaceutics13111748","volume":"13","author":"T Kawano","year":"2021","unstructured":"Kawano T, Inokuchi J, Eto M, Murata M, Kang J-H (2021) Activators and inhibitors of protein kinase C (PKC): their applications in clinical trials. Pharmaceutics 13(11):1748","journal-title":"Pharmaceutics"},{"issue":"6","key":"4075_CR38","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313\u20131321","journal-title":"Hepatology"},{"issue":"1","key":"4075_CR39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jhep.2007.04.002","volume":"47","author":"IA Leclercq","year":"2007","unstructured":"Leclercq IA, Morais ADS, Schroyen B, Van Hul N, Geerts A (2007) Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol 47(1):142\u2013156","journal-title":"J Hepatol"},{"issue":"7","key":"4075_CR40","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/ki.2008.313","volume":"74","author":"MH Lee","year":"2008","unstructured":"Lee MH, Song HK, Ko GJ et al (2008) Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue. Kidney Int 74(7):890\u2013900","journal-title":"Kidney Int"},{"issue":"18","key":"4075_CR41","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.3390\/ijms20184607","volume":"20","author":"SJ Lee","year":"2019","unstructured":"Lee SJ, Kim SJ, Lee H-S, Kwon O-S (2019) PKC\u03b4 mediates NF-\u03ba B inflammatory response and downregulates SIRT1 expression in liver fibrosis. Int J Mol Sci 20(18):4607","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4075_CR42","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.1038\/s41598-017-08334-x","volume":"7","author":"A Li","year":"2017","unstructured":"Li A, Zhang J, Zhang X et al (2017) Angiotensin II induces connective tissue growth factor expression in human hepatic stellate cells by a transforming growth factor \u03b2-independent mechanism. Sci Rep 7(1):7841","journal-title":"Sci Rep"},{"issue":"3","key":"4075_CR43","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3892\/mmr.2020.11326","volume":"22","author":"S Li","year":"2020","unstructured":"Li S, Zhao W, Zhao Z, Cheng B, Li S, Liu C (2020) Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II-induced hepatic stellate cells activation. Mol Med Rep 22(3):2191\u20132198","journal-title":"Mol Med Rep"},{"issue":"14","key":"4075_CR44","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1097\/CM9.0000000000002277","volume":"135","author":"J Liu","year":"2022","unstructured":"Liu J, Tian Y, Fu X et al (2022) Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis. Chin Med J 135(14):1682\u20131691","journal-title":"Chin Med J"},{"issue":"1","key":"4075_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/antiox11010091","volume":"11","author":"Y Ma","year":"2021","unstructured":"Ma Y, Lee G, Heo S-Y, Roh Y-S (2021) Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease. Antioxidants 11(1):91","journal-title":"Antioxidants"},{"issue":"6","key":"4075_CR46","doi-asserted-by":"publisher","first-page":"956","DOI":"10.21037\/hbsn-23-548","volume":"12","author":"R Manikat","year":"2023","unstructured":"Manikat R, Ahmed A, Kim D (2023) Up-to-date global epidemiology of nonalcoholic fatty liver disease. Hepatobil Surg Nutr 12(6):956","journal-title":"Hepatobil Surg Nutr"},{"issue":"19","key":"4075_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38647","volume":"10","author":"T Matsuda","year":"2024","unstructured":"Matsuda T, Kaji K, Nishimura N et al (2024) Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity. Heliyon 10(19):e38647. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38647","journal-title":"Heliyon"},{"key":"4075_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor B, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"issue":"2","key":"4075_CR49","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1440-1746.2008.05597.x","volume":"24","author":"H Murayama","year":"2009","unstructured":"Murayama H, Ikemoto M, Nagata A (2009) Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 24(2):270\u2013277","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"4075_CR50","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1038\/s41598-020-60904-8","volume":"10","author":"A Nagasaki","year":"2020","unstructured":"Nagasaki A, Sakamoto S, Chea C et al (2020) Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation. Sci Rep 10(1):4134","journal-title":"Sci Rep"},{"issue":"2","key":"4075_CR51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/0192623309357951","volume":"38","author":"A Naiki-Ito","year":"2010","unstructured":"Naiki-Ito A, Asamoto M, Naiki T et al (2010) Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol 38(2):280\u2013286","journal-title":"Toxicol Pathol"},{"issue":"5","key":"4075_CR52","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/0192623312441402","volume":"40","author":"A Naiki-Ito","year":"2012","unstructured":"Naiki-Ito A, Kato H, Asamoto M, Naiki T, Shirai T (2012) Age-dependent carcinogenic susceptibility in rat liver is related to potential of gap junctional intercellular communication. Toxicol Pathol 40(5):715\u2013721","journal-title":"Toxicol Pathol"},{"key":"4075_CR53","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1007\/s00204-020-02873-5","volume":"94","author":"A Naiki-Ito","year":"2020","unstructured":"Naiki-Ito A, Kato H, Naiki T et al (2020a) A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats. Arch Toxicol 94:4085\u20134097","journal-title":"Arch Toxicol"},{"issue":"8","key":"4075_CR54","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/carcin\/bgz193","volume":"41","author":"A Naiki-Ito","year":"2020","unstructured":"Naiki-Ito A, Naiki T, Kato H et al (2020b) Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer. Carcinogenesis 41(8):1145\u20131157","journal-title":"Carcinogenesis"},{"key":"4075_CR55","doi-asserted-by":"publisher","DOI":"10.1039\/D4FO00292J","author":"A Naiki-Ito","year":"2024","unstructured":"Naiki-Ito A, Yeewa R, Xiaochen K et al (2024) Hexane insoluble fraction from purple rice extract improves steatohepatitis and fibrosis via inhibition of NF-\u03baB and JNK signaling. Food Funct. https:\/\/doi.org\/10.1039\/D4FO00292J","journal-title":"Food Funct"},{"issue":"7","key":"4075_CR56","doi-asserted-by":"publisher","first-page":"629","DOI":"10.7150\/ijms.17641","volume":"14","author":"M Ohnishi","year":"2017","unstructured":"Ohnishi M, Higuchi A, Matsumura H et al (2017) Involvement of ornithine carbamoyltransferase in the progression of chronic Hepatitis C and liver cirrhosis. Int J Med Sci 14(7):629","journal-title":"Int J Med Sci"},{"issue":"4","key":"4075_CR58","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/j.2040-4603.2013.tb00529.x","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche JE, Saiman Y, Friedman SL (2013) Hepatic stellate cells and liver fibrosis. Compr Physiol 3(4):1473\u20131492","journal-title":"Compr Physiol"},{"issue":"4","key":"4075_CR59","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/tox.22887","volume":"35","author":"GR Romualdo","year":"2020","unstructured":"Romualdo GR, Silva EDA, Da Silva TC et al (2020) Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis. Environ Toxicol 35(4):518\u2013527. https:\/\/doi.org\/10.1002\/tox.22887","journal-title":"Environ Toxicol"},{"issue":"2","key":"4075_CR60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jss.2005.11.062","volume":"130","author":"E Ryer","year":"2006","unstructured":"Ryer E, Liu B, Hom R et al (2006) Protein kinase C-delta negatively regulates migration and proliferation of vascular smooth muscle cells through inhibition of the mitogen activated protein kinase ERK1\/2. J Surg Res 130(2):182\u2013183","journal-title":"J Surg Res"},{"key":"4075_CR61","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00210-019-01706-2","volume":"392","author":"S Saber","year":"2019","unstructured":"Saber S, Khodir AE, Soliman WE et al (2019) Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-\u03baB-TAK1-ERK1\/2 axis in the context of PPAR\u03b3 agonistic activity. Naunyn Schmiedebergs Arch Pharmacol 392:1591\u20131604","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"12","key":"4075_CR62","first-page":"1539","volume":"36","author":"H Sagawa","year":"2015","unstructured":"Sagawa H, Naiki-Ito A, Kato H et al (2015) Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats. Carcinogenesis 36(12):1539\u20131549","journal-title":"Carcinogenesis"},{"issue":"3","key":"4075_CR63","doi-asserted-by":"publisher","first-page":"G582","DOI":"10.1152\/ajpgi.00087.2004","volume":"287","author":"A Satoh","year":"2004","unstructured":"Satoh A, Gukovskaya AS, Nieto JM et al (2004) PKC-\u03b4 and-\u03b5 regulate NF-\u03baB activation induced by cholecystokinin and TNF-\u03b1 in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 287(3):G582\u2013G591","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"4075_CR64","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/tra.12086","volume":"14","author":"T Straube","year":"2013","unstructured":"Straube T, von Mach T, H\u00f6nig E, Greb C, Schneider D, Jacob R (2013) pH-dependent recycling of galectin-3 at the apical membrane of epithelial cells. Traffic 14(9):1014\u20131027","journal-title":"Traffic"},{"issue":"5","key":"4075_CR65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10735-020-09898-1","volume":"51","author":"M-J Sun","year":"2020","unstructured":"Sun M-J, Cao Z-Q, Leng P (2020) The roles of galectins in hepatic diseases. J Mol Histol 51(5):473\u2013484","journal-title":"J Mol Histol"},{"key":"4075_CR66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00535-012-0651-7","volume":"48","author":"Y Tamaki","year":"2013","unstructured":"Tamaki Y, Nakade Y, Yamauchi T et al (2013) Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis. J Gastroenterol 48:491\u2013503","journal-title":"J Gastroenterol"},{"issue":"1","key":"4075_CR67","doi-asserted-by":"publisher","first-page":"2194034","DOI":"10.1080\/21623945.2023.2194034","volume":"12","author":"R Ting","year":"2023","unstructured":"Ting R, Dutton H, Sorisky A (2023) In vitro studies of the renin-angiotensin system in human adipose tissue\/adipocytes and possible relationship to SARS-CoV-2: a scoping review. Adipocyte 12(1):2194034","journal-title":"Adipocyte"},{"issue":"4","key":"4075_CR68","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/oby.2007.114","volume":"16","author":"JE Toblli","year":"2008","unstructured":"Toblli JE, Mu\u00f1oz MC, Cao G, Mella J, Pereyra L, Mastai R (2008) ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. Obesity 16(4):770\u2013776","journal-title":"Obesity"},{"issue":"7","key":"4075_CR69","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14(7):397\u2013411","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"4075_CR70","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.gastro.2009.04.011","volume":"137","author":"J Wang","year":"2009","unstructured":"Wang J, Leclercq I, Brymora JM et al (2009) Kupffer cells mediate leptin-induced liver fibrosis. Gastroenterology 137(2):713-723.e1","journal-title":"Gastroenterology"},{"key":"4075_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.958428","volume":"13","author":"M Wang","year":"2022","unstructured":"Wang M, Li L, Xu Y, Du J, Ling C (2022) Roles of hepatic stellate cells in NAFLD: from the perspective of inflammation and fibrosis. Front Pharmacol 13:958428","journal-title":"Front Pharmacol"},{"issue":"4","key":"4075_CR72","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.2353\/ajpath.2009.080697","volume":"174","author":"Y Wei","year":"2009","unstructured":"Wei Y, Clark SE, Thyfault JP et al (2009) Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats. Am J Pathol 174(4):1329\u20131337","journal-title":"Am J Pathol"},{"issue":"4","key":"4075_CR73","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1159\/000444556","volume":"34","author":"R Weiskirchen","year":"2016","unstructured":"Weiskirchen R, Tacke F (2016) Liver fibrosis: from pathogenesis to novel therapies. Dig Dis 34(4):410\u2013422","journal-title":"Dig Dis"},{"issue":"3","key":"4075_CR74","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2337\/db06-1163","volume":"56","author":"D Westermann","year":"2007","unstructured":"Westermann D, Rutschow S, Jager S et al (2007) Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes 56(3):641\u2013646","journal-title":"Diabetes"},{"key":"4075_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.lfs.2015.12.034","volume":"145","author":"L Wu","year":"2016","unstructured":"Wu L, Mei L, Chong L et al (2016) Olmesartan ameliorates pressure overload-induced cardiac remodeling through inhibition of TAK1\/p38 signaling in mice. Life Sci 145:121\u2013126","journal-title":"Life Sci"},{"issue":"2","key":"4075_CR76","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1158\/0008-5472.CAN-20-2009","volume":"81","author":"K Yamada","year":"2021","unstructured":"Yamada K, Oikawa T, Kizawa R et al (2021) Unconventional secretion of PKC\u03b4 exerts tumorigenic function via stimulation of ERK1\/2 signaling in liver cancer. Can Res 81(2):414\u2013425","journal-title":"Can Res"},{"key":"4075_CR77","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-3-642-83971-9_9","volume-title":"Parallels in cell to cell junctions in plants and animals","author":"H Yamasaki","year":"1990","unstructured":"Yamasaki H (1990) Gap junctional intercellular communication and carcinogenesis. In: Robards AW, Lucas WJ, Pitts JD, Jongsma HJ, Spray DC (eds) Parallels in cell to cell junctions in plants and animals. Springer, Berlin\/Heidelberg, pp 115\u2013127"},{"issue":"6","key":"4075_CR78","doi-asserted-by":"publisher","first-page":"G1190","DOI":"10.1152\/ajpgi.90452.2008","volume":"295","author":"J Yuan","year":"2008","unstructured":"Yuan J, Lugea A, Zheng L et al (2008) Protein kinase D1 mediates NF-\u03baB activation induced by cholecystokinin and cholinergic signaling in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 295(6):G1190\u2013G1201","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4075_CR79","doi-asserted-by":"publisher","DOI":"10.1177\/1470320316628717","author":"Q Zhu","year":"2016","unstructured":"Zhu Q, Li N, Li F et al (2016) Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis. J Renin-Angiotensin-Aldosterone Syst. https:\/\/doi.org\/10.1177\/1470320316628717","journal-title":"J Renin-Angiotensin-Aldosterone Syst"},{"issue":"1\u20133","key":"4075_CR80","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejphar.2006.08.062","volume":"552","author":"S Zorad","year":"2006","unstructured":"Zorad S, Dou J-t, Benicky J et al (2006) Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPAR\u03b3. Eur J Pharmacol 552(1\u20133):112\u2013122","journal-title":"Eur J Pharmacol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04075-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04075-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04075-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:17:45Z","timestamp":1757182665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04075-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["4075"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04075-3","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}